product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
CD21 Antibody (B-E5) [PerCP]
catalog :
NBP3-14587PCP
quantity :
0.1 ml
price :
419 USD
clonality :
monoclonal
host :
mouse
conjugate :
PerCP
clone name :
B-E5
reactivity :
human
application :
flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP3-14587PCP
SKU :
NBP3-14587PCP
product name :
CD21 Antibody (B-E5) [PerCP]
sizes available :
0.1 ml
description :
The CD21 Antibody (B-E5) [PerCP] from NBP3-14587PCP is a 5.7e-05 antibody to . This antibody reacts with human.
target :
CD21
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
B-E5
conjugate :
PerCP
all_available conjugate :
DyLight 755;PerCP
dilution :
Flow Cytometry
host :
Mouse
immunogen :
Daudi cell line
isotype :
IgG2a Kappa
purity :
Affinity purified
species :
Human
gene symbol :
CR2
applications :
Flow Cytometry
USD :
419 USD
alt names :
C3DRSLEB9, CD21, CD21 antigen, Complement C3d receptor, complement component (3d/Epstein Barr virus) receptor 2, complement receptor type 2, Cr2, EBV receptor, Epstein-Barr virus receptor
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- CD21 Antibody (B-E5) [DyLight 550] | NBP3-14587R
- 25-OH Vitamin D3 Antibody-antigen Complex Antibody (RM428) [Alexa Fluor® 488]
- CD21 Antibody (B-E5) [DyLight 350] | NBP3-14587UV
- TRAILR2/TNFRSF10B Antibody (B-D37) [Alexa Fluor® 647] | NBP3-14579AF647
- IL-18 R beta/IL-1 R7/ACPL Antibody (B-B46) [DyLight 405] | NBP3-14574V
questions and comments
